FDA Investigator LT Melanie M Mayor, USPHS

LT Melanie M Mayor, USPHS has conducted inspections on 56 sites in 4 countries as of 06 Oct 2008. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
56
Last Inspection Date:
06 Oct 2008
Investigator Role:
FDA Investigator
Redica ID:
100003574
Countries of Inspections:
United States of America, Poland, Russian Federation, India
FDA Investigators that have inspected at least one site in common with LT Melanie M Mayor, USPHS:
Adriana N Jimenez Lopez, Alan C Gion, Ana P Barido, Andrew R Wasko, Antoine El Hage, PhD, Barbara A Burke, Barbara J Holladay, Brandon L Mariner, Candice C Mandera, Candice J Cortes, Carla C Tuite, Carol Rivera Lopez, PhD, Catherine Whiteside, PhD, Charlean R Butler, Charles A Snipes, PhD, Charles M Kerns, BLT DO, Chris J Drabick, Christine M Whitby, CSO, Courtney N Long, Ct Viswanathan, PhD, Cynthia A Harris, MD, RN, Daniel R Azar, David K Glasgow, David L Chon, Dawn M Collins, Denise R Beuttenmuller, Dennis L Doupnik, Dianne H Milazzo, Dr. Abhijit Raha, PhD, Earl Echon, Eleanor M Felton, Ellen A Humphrey, Elvis D Morton, Emest F Bizjak, Emmanuel A Dimaano, Jr, Esaw, Gale L Glinecki, Gerald N Mcgirl, DDS, Heath R Harley, Hector Jcolon Torres, Holly S Simms, Hugh M Mcclure, II, Iris C Macinnes, Jacqueline A O'shaughnessy, PhD, James T Mccoy, Jamie D Swann, Jeanne D Shaffer, Jeffrey A Reed, Jessica D Nanini, Jessica D Weber, Joey C West, John Dan, John J Welsh, PhD, John Kadavil, PhD, John M Gusto, Johnson, Joseph W Matthews, Karen A Spencer, Kathryn Suttling, Kenneth Nieves, La Tasham Gunter, Lakisha M Williams, LCDR Matthew R Mcnew, MPH, REHS/RS, LCDR Wilfred A Darang, Lori S Lawless, LT Luis O Rodriguez, Lynette P Salisbury, Margaret H Waters, Marilyn M White, Marya F Ricks, Melissa J Garcia, Michael F Skelly, PhD, Michael L Zimmerman, Mike M Rashti, Mildred L Mccray, Mohamad A Chahine, Norman Fogg, Regina Gibson Melton, Renisha M Shaw, Rina Bhikha, Ronald T Nowalk, Shelby W Brown, Jr, Sherry L Secrist, BLT DO, Slatten, Stacey A Priest, Stephanie L Shapley, Stephen C Eason, Steven J Thurber, Susan J Essenmacher, Suzanne M Healy, Tamara N Champion, Tamika E Allen, RN, Teresa L Fox, Timothy M Albright, Tracy L Taras, PhD, Tressa T Lewis, Walter L Fava, Wanda Y Honeyblue, Wayne L Jefferson, William A Warnick, William D Murray, William H Linkroum

LT Melanie M Mayor, USPHS's Documents

Publish Date Document Type Title
June, 2000 EIR Luksenburg Harvey MD - EIR, 2000-06-07
February, 2002 FDA 483 Adam F. Lowy, M.D. - Form 483, 2002-02-04
October, 2001 EIR Experimental Pathology Laboratories, Inc. - EIR, 2001-10-02
March, 2003 EIR Charles F. Lovell, MD - EIR, 2003-03-26
September, 2000 FDA 483 American Histolabs Inc - Form 483, 2000-09-25
December, 2000 FDA 483 Frank M Ludwig MD - Form 483, 2000-12-21
October, 2000 EIR Murdock, Myron I. - EIR, 2000-10-02
March, 2003 FDA 483 Charles F. Lovell, MD - Form 483, 2003-03-26
December, 2000 EIR Mitchell, Robert E. MD - EIR, 2000-12-21
August, 2001 EIR Ore Pharmaceuticals Inc - EIR, 2001-08-15
July, 2000 EIR Finkel, Julia Cole MD - EIR, 2000-07-13
June, 2000 FDA 483 Luksenburg Harvey MD - Form 483, 2000-06-07
February, 2002 FDA 483 Response Adam F. Lowy, M.D. - Form 483R, 2002-02-14
December, 2000 FDA 483 Mitchell, Robert E. MD - Form 483, 2000-12-21
December, 2000 EIR Frank M Ludwig MD - EIR, 2000-12-21
March, 2003 FDA 483 Response Charles F. Lovell, MD - Form 483R, 2003-03-26
August, 2001 FDA 483 Ore Pharmaceuticals Inc - Form 483, 2001-08-15
August, 2001 FDA 483 Response Ore Pharmaceuticals Inc - Form 483R, 2001-08-22
October, 2000 FDA 483 206 Research Medical Director, Mukdock, Francis, PA Urologist Associates - Form 483, 2000-10-02
June, 2002 EIR Covance Laboratories, Inc. - EIR, 2002-06-21
June, 2002 FDA 483 Response Covance Laboratories, Inc. - Form 483R, 2002-06-21
June, 2002 FDA 483 Covance Laboratories, Inc. - Form 483, 2002-06-21
September, 2000 EIR American Histolabs Inc - EIR, 2000-09-25

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more